Brain cancer pilot explores tailored drug cocktails
NCT ID NCT03681028
First seen Feb 13, 2026 · Last updated May 13, 2026 · Updated 15 times
Summary
This study tested whether it's possible to create and start personalized treatment plans quickly for adults with recurrent glioblastoma, a serious brain cancer. Researchers used a special genetic test on tumor tissue to find specific DNA changes and match patients to targeted drugs. The goal was to see if this approach could be done within 35 days after surgery, not to cure the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California San Francisco
San Francisco, California, 94143, United States
Conditions
Explore the condition pages connected to this study.